P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity

Podobne knjige/članki

• 782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton channel mediated toxicity
  od: Ciara Kelly, et al.
  Izdano: (2023-11-01)
• P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity
  od: S Basu, et al.
  Izdano: (2024-03-01)
• G10 is a direct activator of human STING.
  od: Monali Banerjee, et al.
  Izdano: (2020-01-01)
• G10 is a direct activator of human STING
  od: Monali Banerjee, et al.
  Izdano: (2020-01-01)
• Disorders of FZ-CRD; insights towards FZ-CRD folding and therapeutic landscape
  od: Reham M. Milhem, et al.
  Izdano: (2019-12-01)